New York Life Investment Management’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,784
| Closed | -$625K | – | 846 |
|
|
2024
Q4 | $625K | Sell |
15,784
-2,584
| -14% | -$102K | 0.01% | 758 |
|
|
2024
Q3 | $712K | Buy |
18,368
+15
| +0.1% | +$582 | 0.01% | 770 |
|
|
2024
Q2 | $772K | Buy |
+18,353
| New | +$772K | 0.01% | 738 |
|
|
2023
Q1 | – | Sell |
-12,516
| Closed | -$427K | – | 1377 |
|
|
2022
Q4 | $427K | Buy |
12,516
+1,414
| +13% | +$48.2K | ﹤0.01% | 1023 |
|
|
2022
Q3 | $338K | Buy |
11,102
+814
| +8% | +$24.8K | ﹤0.01% | 1053 |
|
|
2022
Q2 | $383K | Buy |
+10,288
| New | +$383K | ﹤0.01% | 1018 |
|